EGLN inhibitor protects normal tissue and enables RT in mouse model of pancreatic cancer
Bottom Line: Administration of the EGLN inhibitor FG-4592 prior to ablative radiotherapy provided protection against fatal gastrointestinal bleeding and improved ...







